πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 677 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7479280

Virus-like particles for the induction of autoantibodies

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7476535

TRP2 isoform TRP2-6b containing HLA-A2 restricted epitopes

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7470506

Fitness assay and associated methods

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7470775

Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7470430

Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7468435

Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related c

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7468352

Mutated anthrax toxin protective antigen proteins that specifically target cells containin

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7465794

Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modul

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7462356

Chimeric papillomavirus-like particles

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7456268

Materials and methods for inhibiting Wip1

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7449190

Assays for assembly of Ebola virus nucleocapsids

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7442543

Mammalian selenoprotein differentially expressed in tumor cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7439226

Serine protease inhibitors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7435801

Antibodies and other ligands directed against KIR2DL4 receptor for production of interfero

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7432349

Tumor suppressor gene, p28ING5

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7431931

Compositions and method for preventing reactogenicity associated with administration of im

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7425218

Nitric oxide-releasing medical devices

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7422755

Antimultiorganism glycoconjugate vaccine

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7410644

Recombinant pox virus for immunization against tumor-associated antigens

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7408075

Synthesis of phosphocholine ester derivatives and conjugates thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7399827

Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7388089

Anti-arthropod vector vaccines method of selecting and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7381744

Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7381405

Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted